<DOC>
	<DOCNO>NCT02428842</DOCNO>
	<brief_summary>Prospective Multicentric European trial Cervical cancer , previously treat , tumour biopsy , blood collection molecular analysis predetermine time point .</brief_summary>
	<brief_title>Biomarker Evaluation Advanced Stage Cervical Cancer International Working Group . Tumor Stages ( 1B1 - 4 )</brief_title>
	<detailed_description />
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<criteria>1 . No prior treatment cervical cancer . 2 . FIGO Stage IB1 IVB ; histological subtypes ( exclude neuroendocrine type ) . 3 . Pelvic MRI available planned start treatment , , FIGO ≥ IB2 . optional IB1 stage 4 . Possibility communicate image data CDROM ( format DICOM 3.0 ) . 5 . Disease amenable biopsy ( 3 tumour sample mandatory prior treatment ) . 6 . Age ≥ 18 year . 7 . ECOG ( Eastern Cooperative Oncology Group ) 02 . 8 . Life expectancy &gt; 6 month . 9 . Patient eligible standard treatment ( accord standard center ) . 10 . Patient health care insurance . 11 . Informed signed consent patient . ( DICOM = Digital Imaging Communications Medicine ) 1 . Patient enrol clinical trial involve investigative new agent . 2 . Co morbidity , prevent patient tolerate propose standard treatment . 3 . Past history invasive cancer 5 year precede entry present trial ( except basal cell carcinoma carcinoma situ cervix ) . 4 . Impossibility carry evaluation MRI ( patient claustrophobic , pacemaker , metallic implant , non availability , ) , ) , FIGO ≥ IB2 . 5 . Patient deprive ability decide . 6 . Patient unable regular follow geographical , social psychological reason . 7 . Pregnancy patient old enough procreate use effective contraceptive method .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Cervical cancer</keyword>
	<keyword>Tumor biopsy</keyword>
	<keyword>Standard treatment</keyword>
	<keyword>Molecular profile</keyword>
	<keyword>Next Generation Sequencing</keyword>
</DOC>